Prostate Cell News Volume 17.08 | May 15 2026

    0
    26






    2026-05-15 | PCN 17.08


    Prostate Cell News by STEMCELL Technologies
    Vol. 17.08 – 15 May, 2026
    TOP STORY

    An Orally Bioavailable Pan-αV/α5β1 Integrin Antagonist Prevents Aggressive Prostate Cancer Progression via Suppressing Both Oncogenic Signals and CD47-Mediated Immune Escape

    In preclinical models, C19-9N overcame enzalutamide resistance in CRPC xenografts, suppressed bone metastatic progression, and exhibited superior efficacy to platinum/taxane therapies in neuroendocrine prostate cancer.
    [Molecular Cancer]

    Abstract
    PUBLICATIONSListed by the impact factor of the journal

    MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer

    The authors identified ecotropic viral integration site 1 (EVI1) as an androgen receptor (AR)-recruited coactivator of noncanonical signaling. In prostate cancer, MECOM was exclusively overexpressed in both CRPC and enzalutamide-resistant CRPC and interacted with AR in the nucleus.
    [Cancer Research]

    Full Article

    LGALS9 Blockade Augments Vaccine-Induced Immune Responses against Prostate Cancer

    Scientists generated recombinant adenoviral vaccines encoding PSMA and LGALS9 for antigen expression in vitro and in vivo. They evaluated therapeutic efficacy in murine subcutaneous, bone metastatic, and humanized prostate cancer models.
    [Journal for Immunotherapy of Cancer]

    Full Article

    First-in-Human Single-Cell and TCR Atlas Reveals Peripheral Immune Remodeling Before and after Irreversible Electroporation in Prostate Cancer

    Researchers presented a detailed analysis of paired single-cell data collected before and after irreversible electroporation (IRE). They provided a first-in-human atlas of peripheral immune remodeling after IRE in localized prostate cancer.
    [Journal for Immunotherapy of Cancer]

    Abstract

    HOXD11-NMDAR Signaling Drives Neuroendocrine Prostate Cancer and Enables Potential Therapeutic Intervention As a Target of Memantine

    Using single-cell RNA sequencing of transgenic adenocarcinoma of the mouse prostate mice across pathological stages, investigators found an early neuroendocrine-initiating cluster marked by elevated HOXD11, conserved in human neuroendocrine prostate cancer.
    [Cell Reports]

    Full Article

    Molecular Insights into DDX3X-Androgen Receptor mRNA Regulation via Non-Canonical G-Quadruplex in Castration-Resistant Prostate Cancer

    Scientists showed that DEAD-box helicase 3 X-linked (DDX3X) colocalizes with androgen receptor (AR) mRNA in androgen receptor-low/negative CRPC cells and selectively recognizes non-canonical RNA G-quadruplex motifs within the sequence of AR mRNA.
    [Oncogene]

    Full Article

    The RPS15-DDX21 Complex Drives Prostate Malignancy through Transcriptional Activation of SCD1

    Researchers demonstrated that RPS15 significantly promotes proliferation and migration in prostate cancer through the establishment of ribosomal protein S15 (RPS15) knockdown cells and xenograft models.
    [Oncogene]

    Abstract
    Scientific resources to support your organoids research. Learn More!
    REVIEWS

    Oligometastatic Prostate Cancer — Bridging the Gap between Localized and Metastatic Disease

    Results from randomized Phase II trials support the use of metastasis-directed therapy in patients with metachronous oligometastatic prostate cancer. In parallel, prostate-directed treatments such as radiotherapy and cytoreductive radical prostatectomy are under investigation.
    [Nature Reviews Urology]

    Abstract

    Decoding the Raf-Mek-Erk-Rsk Pathway in Prostate Cancer: From Molecular Mechanisms to Clinical Opportunities

    Whilst inhibitors of the RAF-MEK-ERK-RSK pathway have demonstrated clinical utility in other cancers this has not been realized in prostate cancer. The reasons for this include a lack of predictive biomarkers for, and the unique landscape of pathway activation.
    [British Journal of Cancer]

    Full Article

    The Microbiome across the Prostate Disease Continuum: From Health and BPH to Prostatitis/CPPS and Cancer

    By integrating mechanistic, spatial, and clinical evidence, the authors propose a stage-aware framework for the gut–urinary–prostatic axis and delineate when microbial and metabolite signalling meaningfully conditions prostate disease biology—and when it does not.
    [Oncogene]

    Abstract
    INDUSTRY AND POLICY NEWS

    Fred Hutch Researchers Receive Prostate Cancer Foundation Young Investigator Awards

    Drs. Pallabi Mustafi and Ruben Raychaudhuri received Young Investigator Awards from the Prostate Cancer Foundation for their work investigating epigenetic features of aggressive prostate cancer that could lead to more personalized care and better results from existing therapies.
    [Fred Hutch Cancer Center]

    Press Release

    Does the PSA Test for Prostate Cancer Save Lives? New Data Reverse Gold-Standard Findings

    Does prostate-cancer screening with the common ‘PSA’ blood test save lives? The Cochrane has previously addressed that question twice, and twice the answer was ‘no’. Data from nearly 800,000 people has prompted a U-turn.
    [Nature]

    News
    FEATURED EVENT

    Frontiers in Cancer Immunotherapy

    June 22-23, 2026
    New York City, New York, United States

    > See All Events

    JOB OPPORTUNITIES

    Research Assistant – Oncological Biomarkers in Prostate Cancer

    Case Western Reserve University – Cleveland, Ohio, United States

    Postdoctoral Research Fellow – Functional Genomics & CRISPR

    Fred Hutchinson Cancer Center – Seattle, Washington, United States

    Postdoctoral Fellowships – Computational Biology

    The University of Texas MD Anderson Cancer Center – Houston, Texas, United States

    Full Professorship – Early Cancer Detection

    Heidelberg University – Heidelberg, Germany

    Tenure-Track Professor/Associate Professor/Assistant Professor – Biomedical Sciences

    The University of Hong Kong – Hong Kong

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2